Zhao Lab

With the advance of high-throughput genome sequencing and precision medicine, the Zhao Lab is exploring the genetic basis of cardiovascular development and congenital heart disease using patient-derived induced pluripotent stem cells (iPSCs). We are thrilled to establish the first iPSC Genomics laboratory in the Center for Cardiovascular Research at Nationwide Children’s Hospital, and are currently transforming our understandings on the genetic mechanisms of congenital heart disease using patient-derived cardiomyocytes, endothelial cells, and smooth muscle cells. Collaborating with principal investigators in The Heart Center at Nationwide Children’s Hospital and The Ohio State University Wexner Medical Center, we are positioned to advance our perception on congenital heart disease using both human iPSCs and mouse/zebrafish/pig models. In addition, we are using genome editing tools (CRISPR/Cas9) to correct/introduce genetic variants in the context of normal and diseased heart cells originally from the patients and study how a particular genetic variant could contribute to congenital heart defects.

Meet Our Team

Previous Works in the Lab

We're Recruiting!

The Zhao Lab is looking for motivated, curious and dedicated postdocs and graduate students. 

Connect With Our Team

Featured Researcher – Mingtao Zhao, DVM, PhD

Dr. Mingtao Zhao was selected as the Abigail Wexner Research Institute featured researcher in June 2021. Click the button below to learn more about Dr. Zhao and his work in the Center for Cardiovascular Research.

Learn More

Connect With Our Team

Interested in collaborating with or joining the Zhao Lab? Complete the form below to connect.